Históndeasetýlasahemlar

摘要

The invention concerns a compound of the formula (I); wherein Ring A is heterocyclyl; m is 0-4 and each RSUP1 /SUPis a group such as hydroxy, halo, trifluoromethyl and cyano; Ring B is ring such as thienyl, thiadiazolyl, thiazolyl, pyrimidyl, pyrazinyl, pyridazinyl and pyridyl; RSUP2 /SUPis halo and n is 0-2; and each RSUP4 /SUPis a group such as hydroxy, halo, trifluoromethyl and cyano; p is 0-4; and RSUP3 /SUPis amino or hydroxy; or pharmaceutically-acceptable salts or in-vivo-hydrolysable ester or amide thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by histone deacetylase.